Compare uniQure N.V. Ordinary Shares (QURE) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs S&P Global Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while S&P Global Inc trades at $412.5 (market cap $120.45B). The key difference: S&P Global Inc is far larger — about 83.1× uniQure N.V. Ordinary Shares's market cap, and S&P Global Inc pays a 0.95% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and S&P Global Inc for 124 Days on average.
| QURE | SPGI | |
|---|---|---|
Market Cap | $1.45B | $120.45B |
Volume | 3,323,243 | 1,198,667 |
Sector | Health | Financials |
52-Week High | $70.59 | $517.92 |
52-Week Low | $9.03 | $370.42 |
Typical Hold Time | 0 Days | 124 Days |
Enterprise Value | $707.46M | $131.93B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPGI trades at $409.99, down 0.53% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong revenue growth to $15.34 billion in 2025, with net income reaching $4.47 billion and a robust net margin of 30.54%. Recent developments include the acquisition of OpenZeppelin and the launch of new risk assessment services, expanding its market intelligence offerings.
The outlook remains positive with analyst consensus strongly bullish, an average price target of $509.50 implying significant upside. Risks include high valuation multiples and exposure to economic cycles, but sustained profitability and strategic expansions support long-term growth potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
